TCM Pharmacology Based on Bibliometrics and Patent Analysis： A Case Study of Institute of Chinese Materia Medica， China Academy of Chinese Medical Sciences
10.13422/j.cnki.syfjx.20241508
- VernacularTitle:基于文献计量学及专利分析的中药药理学学科进展——以中国中医科学院中药研究所为例
- Author:
Lin ZHANG
1
;
Yuhan DENG
2
;
Yanwen LI
3
;
Luming QIU
1
;
Sijia MA
4
;
Tuo LIU
5
;
Zhiyong LI
5
;
Yujie LI
5
Author Information
1. Shandong University of Traditional Chinese Medicine，Jinan 250301， China
2. School of Pharmacy，Minzu University of China，Beijing 100081，China
3. Institute of Information on Traditional Chinese Medicine，China Academy of Chinese Medical Sciences，Beijing 100700，China
4. School of Information Engineering，Minzu University of China，Beijing 100081，China
5. Institute of Chinese Materia Medica，China Academy of Chinese Medical Sciences，Beijing 100700，China
- Publication Type:Journal Article
- Keywords:
traditional Chinese medicine （TCM） pharmacology;
bibliometrics;
academic track;
patent analysis;
development trend
- From:
Chinese Journal of Experimental Traditional Medical Formulae
2024;30(23):8-18
- CountryChina
- Language:Chinese
-
Abstract:
ObjectiveTo analyze the literature related to traditional Chinese medicine （TCM） pharmacology of Institute of Chinese Materia and Medica， China Academy of Chinese Medical Sciences （hereinafter referred to as "Institute of Chinese Materia and Medica"）， and evaluate the research status， development trend， influence of discipline members， and patent technology of this field. MethodThe papers from 2002 to 2024 in the databases of CNKI and Web of Science （WOS） were searched， whose first authors or corresponding authors are from the Institute of Chinese Materia and Medica， and CiteSpace 6.3.R6 was adopted for visual analysis of the annual number of publications and keywords. Additionally， the total number of published papers， citation times， and other measurement parameters of discipline members of TCM pharmacology in the institute were counted. After obtaining the h index， the academic track was calculated， and the academic influence of discipline members was quantitatively evaluated from the aspects of the academic track T and highly cited papers. Meanwhile， patent data from 2005 to 2024 of TCM pharmacology in the studied institute were retrieved from the HimmPat patent database， and Excel 2022 and Origin 2021 were utilized to conduct visual analysis on the overall patent application trend and technology composition. ResultIn the past 20 years or more， the annual publication of academic papers has been on the rise generally， and the key words include "animal model"， "mechanism of action"， "network pharmacology" and so on. The studies focus on the innovative methods of TCM pharmacological mechanisms， basic research on TCM prevention and treatment of major non-infectious diseases， and the prevention and treatment of respiratory viral diseases. The academic track T of the discipline members of TCM pharmacology in the Institute of Chinese Materia and Medica is positive， with sound personal influence. In recent years， the patent application trend has increased significantly， mainly concentrating on A61K patents and G01N subcategories， and IPC large-group analysis shows that the main technical applications are mainly in A61K36， A61K31， and other fields. ConclusionTCM pharmacology in the institute develops steadily and the academic influence of the discipline members is still sound， with fruitful patent achievements. In the future， research on pharmacological discipline innovation and new drug research and development can be enhanced， and multidisciplinary integration studies should be carried out to promote TCM modernization.
